OlyCAR-019 / 920th Hospital of Joint Logistics Support Force of the Chinese People's Liberation Army - LARVOL DELTA

A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies (clinicaltrials.gov) - P1/2 | N=60 | Recruiting | Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

New P1/2 trial • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology